The book adds to the discussion about strategic approaches towards the translation of
personalized medicine into clinical practice. It stresses the importance of non-science related
institutional barriers. A Law and Economics perspective is applied in order to examine the
incentives induced by the barriers. An applied part identifies and evaluates policy levers to
foster the translation of personalized medicine into Swiss clinical practice.
